about
Selective inhibition of anthrax edema factor by adefovir, a drug for chronic hepatitis B virus infectionHuman alpha-defensins neutralize anthrax lethal toxin and protect against its fatal consequencesBinary bacterial toxins: biochemistry, biology, and applications of common Clostridium and Bacillus proteinsHuman monoclonal antibodies against anthrax lethal factor and protective antigen act independently to protect against Bacillus anthracis infection and enhance endogenous immunity to anthraxAnthrax vaccine design: strategies to achieve comprehensive protection against spore, bacillus, and toxinEffective antiprotease-antibiotic treatment of experimental anthraxObstructing toxin pathways by targeted pore blockageThe structural basis for substrate and inhibitor selectivity of the anthrax lethal factorIdentification of small molecule inhibitors of anthrax lethal factorATR/TEM8 is highly expressed in epithelial cells lining Bacillus anthracis' three sites of entry: implications for the pathogenesis of anthrax infectionHomologous versus heterologous interactions in the bicomponent staphylococcal gamma-haemolysin pore.Unified superresolution experiments and stochastic theory provide mechanistic insight into protein ion-exchange adsorptive separations.Phage display of random peptide libraries: applications, limits, and potential.Peptide inhibitors MAP the way towards fighting anthrax pathogenesis.Polyvalent inhibitors of anthrax toxin that target host receptorsInter-alpha-inhibitor proteins are endogenous furin inhibitors and provide protection against experimental anthrax intoxication.EGFR-targeted hybrid plasmonic magnetic nanoparticles synergistically induce autophagy and apoptosis in non-small cell lung cancer cells.Blocking anthrax lethal toxin at the protective antigen channel by using structure-inspired drug design.Development of homomultimers and heteromultimers of lung cancer-specific peptoids.Computational model for nanocarrier binding to endothelium validated using in vivo, in vitro, and atomic force microscopy experiments.Direct inhibition of T-lymphocyte activation by anthrax toxins in vivo.Passive protection against anthrax by using a high-affinity antitoxin antibody fragment lacking an Fc regionPhage display against corneal epithelial cells produced bioactive peptides that inhibit Aspergillus adhesion to the corneasA chimeric protein that functions as both an anthrax dual-target antitoxin and a trivalent vaccine.Enhancing the affinity of SEB-binding peptides by repeating their sequence.A FRET-based high throughput screening assay to identify inhibitors of anthrax protective antigen binding to capillary morphogenesis gene 2 proteinIdentification of exosite-targeting inhibitors of anthrax lethal factor by high-throughput screeningSmall molecule inhibitors of Bacillus anthracis protective antigen proteolytic activation and oligomerization.Panning of a phage display library against a synthetic capsule for peptide ligands that bind to the native capsule of Bacillus anthracisDetection of anthrax toxin in the serum of animals infected with Bacillus anthracis by using engineered immunoassaysAnthrax toxin: a tripartite lethal combination.Designing inhibitors of anthrax toxinAnthrax toxins and the host: a story of intimacy.Anthrax toxin: structures, functions and tumour targeting.Inhibition of anthrax protective antigen outside and inside the cell.Identification of Fusarium virguliforme FvTox1-Interacting Synthetic Peptides for Enhancing Foliar Sudden Death Syndrome Resistance in Soybean.Antitoxins: novel strategies to target agents of bioterrorism.A dually active anthrax vaccine that confers protection against both bacilli and toxins.Inhibitors of the Metalloproteinase Anthrax Lethal Factor.Multivalent Conjugates of Sonic Hedgehog Accelerate Diabetic Wound Healing.
P2860
Q24311064-EA34BFD0-73B1-4F9E-8418-D676AB2F363FQ24555744-116CCB82-961C-4AA8-8FC4-F2E4C420117CQ24562788-E788B73B-A9E6-4100-B458-F3F63867DF5AQ24682011-475F9618-A2FA-4AD9-B07F-7A55ADF33713Q24796044-FEC183F3-E3E6-434D-8119-EC70D267532CQ24799393-624D7C0C-E214-4996-9FBD-C7D51CF9AA3AQ26827489-86B9B962-AC30-41D1-9473-A96A6A36D98FQ27642935-49611BE0-F8CF-4E24-8A62-9F02E66BA24CQ27642936-46009D65-6672-4BEC-A2A3-359196E1AF57Q28305638-8BB71886-9AB7-4F70-9B99-05D973725150Q30160102-3203B5F9-BCCC-4FFC-9931-ECB4D8BFDF8CQ30572024-22ADF9B3-B7D1-451B-836A-21A1D78CC202Q31039269-7FF0921C-D652-4BEA-A560-BDEA7F92BCF2Q33236706-C897983C-1485-49E3-B05A-122B1CB18E3EQ33255666-935B50DD-CDE8-4BAA-AE0B-8BE971A886C5Q33946836-ED86C677-84BC-4C48-8902-D44FA39FDECFQ34075391-3777CE97-D69C-4CAE-9327-A0CB0B27384EQ34085124-BF8945DE-5E5D-412E-AAD6-CFCD5770F3A9Q34105317-71235793-5BD9-4276-BDC6-FFBE13BCBD5AQ34151664-ADA79F5B-CC89-4468-9BAD-7ACA50DE2BE5Q34194649-AB2CF147-0BED-4A55-974D-3FB85991045EQ34194728-7C1D022F-98D9-49C7-A196-C52BCE887354Q34201102-FB99FC2A-37E6-46CF-A793-BC37D11E29C3Q34289944-8A1178D9-249D-49C8-AABF-6DA97A31465DQ34317080-DFCF9881-7886-44D9-BEA5-46631FD01F75Q34328401-6DC78A2D-4192-4D7F-B81E-924455232CFCQ34355048-9B786C41-16E2-4C07-955E-492FCD1CC49FQ34407314-02E216CE-5033-45E1-80E0-F84658DB0B76Q34429143-8373E4D1-4CC7-43F9-9A13-C234134647D1Q34720183-2812D718-2F4C-4B85-BA0F-56C96610C5DFQ34999660-46AC93CF-D8E5-47E2-8652-1177740239C7Q35018313-369C0E53-D023-48EB-933D-7686D981ED92Q35050924-B0CD6EA6-9716-4AF2-BA2A-23E236730FC2Q35184740-69015B44-E194-47C1-9F6F-770FFDA7C395Q35635676-45A35C10-E81C-495D-880A-EE3DCCD7C2BDQ35879438-DF1FC0A1-A420-47F4-852D-222ACF10483BQ35889591-1287B5D7-C54E-4E42-82B3-9FFD6F523EB1Q35978682-036DFEC8-7860-4E16-9502-52FB68DCB89DQ35987872-C46B03A7-D713-4E57-AA14-065E6F21D043Q36011804-ED9DD277-A79B-4DED-8429-F4A054CFD1F1
P2860
description
2001 nî lūn-bûn
@nan
2001 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Designing a polyvalent inhibitor of anthrax toxin.
@ast
Designing a polyvalent inhibitor of anthrax toxin.
@en
type
label
Designing a polyvalent inhibitor of anthrax toxin.
@ast
Designing a polyvalent inhibitor of anthrax toxin.
@en
prefLabel
Designing a polyvalent inhibitor of anthrax toxin.
@ast
Designing a polyvalent inhibitor of anthrax toxin.
@en
P2093
P2860
P356
P1433
P1476
Designing a polyvalent inhibitor of anthrax toxin.
@en
P2093
Deschatelets P
Mogridge J
Sellman BR
Whitesides GM
P2860
P2888
P304
P356
10.1038/NBT1001-958
P577
2001-10-01T00:00:00Z